Home / Resource Library / Orelabrutinib Plus RCHOP Effective for Extranodal, Non-GCB Diffuse Large B-Cell LymphomaOrelabrutinib Plus RCHOP Effective for Extranodal, Non-GCB Diffuse Large B-Cell Lymphoma ESMO 2022